Yu Chung Tsang

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi et al. · The Lancet Haematology · 2020 · 68 citations

Drug Safety, Transfusion-dependent Haemoglobinopathies, Pediatric Hematology +8

High Variability in Drug Pharmacokinetics Complicates Determination of Bioequivalence: Experience with Verapamil

Yu Chung Tsang, Radu Pop, Paul Gordon et al. · Pharmaceutical Research · 1996 · 33 citations

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop summary report

Mei‐Ling Chen, Vinod P. Shah, Daan J.A. Crommelin et al. · European Journal of Pharmaceutical Sciences · 2011 · 26 citations

Drug Repositioning, Bioequivalence, Pharmacology +8

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report

Mei‐Ling Chen, Vinod P. Shah, Daan J.A. Crommelin et al. · The AAPS Journal · 2011 · 17 citations · Full text

Drug Repositioning, Bioequivalence, Pharmacology +8

Effects of renal impairment on the pharmacokinetics of orally administered deferiprone

Caroline Fradette, Vincent Pichette, Éric Sicard et al. · British Journal of Clinical Pharmacology · 2016 · 12 citations · Full text